Thursday, May 18, 2017
- 5:30PM-7:00PM
-
Abstract Number: 76
Applying 2016 MAS Criteria to Systemic onset Juvenile Idiopathic Arthritis Patients with Diagnosis of Macrophage Activation Syndrome
Clinical and Therapeutic Poster Session- 5:30PM-7:00PM
-
Abstract Number: 116
Arthritis as First Presenting Symptom of Inflammatory Bowel Disease: A Case Control Study
Clinical and Therapeutic Poster Session- 5:30PM-7:00PM
-
Abstract Number: 87
Assessment of Endothelial Dysfunction and Atherogenic Risk Factors in Children with Juvenile Dermatomyositis
Clinical and Therapeutic Poster Session- 5:30PM-7:00PM
-
Abstract Number: 106
Atypical manifestations and main misdiagnoses of Takayasu’s arteritis in childhood: a multicenter study of 71 patients
Clinical and Therapeutic Poster Session- 5:30PM-7:00PM
-
Abstract Number: 131
Balancing JAK/STAT-signaling with tofacitinib may foster anti-inflammatory functions of human monocytes
Genetics and Pathogenesis Poster Session- 5:30PM-7:00PM
-
Abstract Number: 65
Barriers at School for Children with Juvenile Idiopathic Arthritis (JIA) –A Patient Reported Outcome
Clinical and Therapeutic Poster Session- 5:30PM-7:00PM
-
Abstract Number: 47
Baseline characteristics of the first 123 patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance Start Time Optimization of Biologic Therapy in Polyarticular JIA comparative effectiveness study
Clinical and Therapeutic Poster Session- 5:30PM-7:00PM
-
Abstract Number: 74
Benefit of Anakinra in Treating Pediatric Secondary Hemophagocytic Lymphohistiocytosis
Clinical and Therapeutic Poster Session- 5:30PM-7:00PM
-
Abstract Number: 97
Bortezomib is Efficacious in the Treatment of Refractory Neuropsychiatric SLE with Psychosis
Clinical and Therapeutic Poster Session- 5:30PM-7:00PM
-
Abstract Number: 55
Celiac Disease in Children Diagnosed with Juvenile Idiopathic Arthritis
Clinical and Therapeutic Poster Session- 5:30PM-7:00PM
-
Abstract Number: 129
Cell-bound Complement Activation Products Correlate with Disease Activity in Childhood-onset Systemic Lupus Erythematosus
Genetics and Pathogenesis Poster Session- 5:30PM-7:00PM
-
Abstract Number: 126
Challenges in Transitioning Adolescents with Rheumatologic Diseases to Adult Care – The Brazilian Experience
Clinical and Therapeutic Poster Session- 5:30PM-7:00PM
-
Abstract Number: 108
Characteristics and long-term outcome of children and adolescents with initial diagnosis of Behçet’s disease in a tertiary care center in Brazil
Clinical and Therapeutic Poster Session- 5:30PM-7:00PM
-
Abstract Number: 85
Characteristics of anti-MDA5 autoantibody-associated Juvenile Dermatomyositis (JDM) in North America